October 14, 2025 – Inventiva (Euronext Paris and Nasdaq : IVA) (“Inventiva” or the “Company”), a clinical-stage ...
Canaan ( ($CAN) ) has shared an update. On October 24, 2025, Canaan Inc. announced the launch of a new at-the-market equity offering program, ...
Inventiva ( (IVA) ) has shared an announcement. On October 14, 2025, Inventiva announced the implementation of a new At-The-Market (ATM) program, filing a shelf registration statement with the SEC to ...
Financial Highlights for the third quarter ended September 30, 2025 The Company’s unaudited interim condensed consolidated financial statements for the nine months ended September 30, 2025, are ...
Q3 2025 Earnings Call October 28, 2025 4:30 PM EDTCompany ParticipantsBill Roeschlein - Chief Financial OfficerZvi Alon ...
ETHZilla has pivoted from biotech to become a major Ethereum treasury and infrastructure company, holding 102,326 ETH worth ...
Daix (France), New York City (New York, United States), October 14, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback